Skip to main content
Equibles

DHTI · Dalrada Technology Group, Inc.

Track DHTI — free

Use DHTI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DHTI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.02 +0.01 (+87.50%) At close · Oct 19
Rebalance outlook locked
Going-concern doubt — flagged May 21, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The Company continues to incur recurring operating losses, negative cash flows from operations, and significant working capital deficits, which raise substantial doubt regarding the Company's ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued.”
View the 10-Q filed May 21, 2026
Market Cap
$1.08M
Shares
120.16M
Volume · Oct 19 37.5K Avg daily vol (3M) 43.75K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.02 Open$0.01 Day$0.01–0.02 52W close$0.00–0.07 Avg vol 30d23K Short int166 · 0.0% float · 1.0d Short vol4% DataJan 2021–Oct 2026 Filing10-Q · May 21

Up next

Latest filing: 10-Q
filed May 21, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$16.51M
Trailing 12 months
Net income (TTM)
−$21.75M
Trailing 12 months
Revenue growth YoY
-43.9%
Year over year
Operating margin
-108.6%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$82,625
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+16.7%
Year over year · more shares
Price change (1Y)
-78.4%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
View all 122 metrics

Quarterly results

Revenue Net income Net loss
▼34.5% $7.04M −$7.92M '24 Q4* ▲20.2% $6.03M −$6.80M '25 Q1 ▼28.5% $3.11M −$6.71M '25 Q2 ▲33.4% $4.57M −$4.20M '25 Q3 ▼6.5% $6.58M −$6.94M '25 Q4* ▼32% $4.10M −$6.06M '26 Q1 ▲4.7% $3.26M −$4.42M '26 Q2 LATEST ▼43.9% $2.57M −$4.33M '26 Q3

* Q4 derived as the full year minus Q1 to Q3.

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Buy Momentum Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 18.4 · elevated Equity put/call 0.55
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg −45%
below
Price vs 50-day avg +34%
above
RSI (14) 56
neutral
MACD trend Positive
52-week position 19%
mid-range
Momentum
relative strength
Weak
1-month return +81%
trailing
6-month return −50%
trailing
YTD return −55%
this year
Relative strength −58%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of float · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Squeeze score 21
low risk · 0–100
Fundamentals
Strong
Revenue growth +2%
Y/Y
Gross margin 26%
expanding
EPS growth +26%
Y/Y
Free cash flow $-18.3M
Quant / Vol
risk profile
Very High
Volatility 531%
annualized · 1-yr
Max drawdown −94%
past year
ATR 26.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−45% Bearish
Price vs 50-day avg
+34% Bullish
RSI (14)
56 Neutral
MACD trend
Positive Bullish
52-week position
19% Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of float · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0 Now $0 · 19% Range high $0
vs 200-day avg -45% vs 50-day avg +34%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Pharmaceutical Retailers — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
DHTI
Dalrada Technology Group, Inc.
this stock
$1.08M -54.5% +2.3% — 0.0%
RTEZ
REST EZ Inc.
 $4.20B — -100.0% — 0.0%
HITI
High Tide Inc.
 $233.55M +0.0% — — 0.8%
BHIC
BioScience Health Innovations, Inc.
 $79.68M — +208.3% — 0.0%
SHFH
Scientist Home Future Health Ltd
 $40.32M — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
166
Days to cover
1.0d
Change
+166 sh
View
Short Volume
Short vol %
4%
As of
Oct 19, 2026
Short Total
View
Fails to Deliver
FTD shares
99
Value
$5
As of
Feb 3, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$20.3M
Net income (FY)
$-24.6M
EPS diluted
$-0.23
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 7, 2026
This year
10
View

Performance

5D 20D 120D MTD YTD
DHTI +12.8% +80.7% -50.0% +63.0% -54.6%
SPY -1.5% -0.9% +7.7% +0.5% +12.4%
vs SPY +14.3% +81.6% -57.7% +62.5% -67.0%
Key facts CIK 725394 Visit website Investor relations